Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tinka Tuinstra is active.

Publication


Featured researches published by Tinka Tuinstra.


Neurobiology of Disease | 2006

Differential regulation of the CXCR2 chemokine network in rat brain trauma: Implications for neuroimmune interactions and neuronal survival

Astrid Vallès; Lindsay Grijpink-Ongering; Freddy M. de Bree; Tinka Tuinstra; Eric Ronken

Chemokine receptors represent promising targets to attenuate inflammatory responses and subsequent secondary damage after brain injury. We studied the response of the chemokines CXCL1/CINC-1 and CXCL2/MIP-2 and their receptors CXCR1 and CXCR2 after controlled cortical impact injury in adult rats. Rapid upregulation of CXCL1/CINC-1 and CXCL2/MIP-2, followed by CXCR2 (but not CXCR1), was observed after injury. Constitutive neuronal CXCR2 immunoreactivity was detected in several brain areas, which rapidly but transiently downregulated upon trauma. A second CXCR2-positive compartment, mainly colocalized with the activated microglia/macrophage marker ED1, was detected rapidly after injury in the ipsilateral cortex, progressively emerging into deeper areas of the brain later in time. It is proposed that CXCR2 has a dual role after brain injury: (i) homologous neuronal CXCR2 downregulation would render neurons more vulnerable to injury, whereas (ii) chemotaxis and subsequent differentiation of blood-borne cells into a microglial-like phenotype would be promoted by the same receptor.


Journal of Cerebral Blood Flow and Metabolism | 2010

Cerebral Blood Volume Alterations in the Perilesional Areas in the Rat Brain after Traumatic Brain Injury—Comparison with Behavioral Outcome

Riikka Immonen; Taneli Heikkinen; Leena Tähtivaara; Antti Nurmi; Taina-Kaisa Stenius; Jukka Puoliväli; Tinka Tuinstra; Amie L Phinney; Bernard J. Van Vliet; Juha Yrjänheikki; Olli Gröhn

In the traumatic brain injury (TBI) the initial impact causes both primary injury, and launches secondary injury cascades. One consequence, and a factor that may contribute to these secondary changes and functional outcome, is altered hemodynamics. The relative cerebral blood volume (CBV) changes in rat brain after severe controlled cortical impact injury were characterized to assess their interrelations with motor function impairment. Magnetic resonance imaging (MRI) was performed 1, 2, 4 h, and 1, 2, 3, 4, 7, and 14 days after TBI to quantify CBV and water diffusion. Neuroscore test was conducted before, and 2, 7, and 14 days after the TBI. We found distinct temporal profile of CBV in the perilesional area, hippocampus, and in the primary lesion. In all regions, the first response was drop of CBV. Perifocal CBV was reduced for over 4 days thereafter gradually recovering. After the initial drop, the hippocampal CBV was increased for 2 weeks. Neuroscore demonstrated severely impaired motor functions 2 days after injury (33% decrease), which then slowly recovered in 2 weeks. This recovery parallelled the recovery of perifocal CBV. CBV MRI can detect cerebrovascular pathophysiology after TBI in the vulnerable perilesional area, which seems to potentially associate with time course of sensory-motor deficit.


Archive | 2004

Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors

Jacobus A. J. den Hartog; Gustaaf J. M. Van Scharrenburg; Herman H. van Stuivenberg; Tinka Tuinstra; Jan-Willem Terpstra


Archive | 2004

Bicyclo`3.1.1!heptane substituted benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors

Hartog Jacobus A. J. Den; Samuel David; Daniel Jasserand; Scharrenburg Gustaaf J M Van; Stuivenberg Herman H. Van; Tinka Tuinstra


Archive | 2003

Neurotensin active 2,3,diaryl-pyrazolidine derivatives

Roelof W. Feenstra; Josephus H. M. Lange; Maria L. Pras-Raves; Cornelis G. Kruse; Herman H. van Stuivenberg; Tinka Tuinstra; Hiskias G. Keizer


Archive | 2004

Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors

Jacobus A. J. den Hartog; Samuel David; Daniel Jasserand; Gustaaf J. M. Van Scharrenburg; Herman H. van Stuivenberg; Tinka Tuinstra


Archive | 2004

Derives de benzimidazolone et de quinazolinone en tant qu'agonistes sur des recepteurs orl1 humains

Hartog Jacobus A. J. Den; Scharrenburg Gustaaf J M Van; Herman H. Stuivenberg; Tinka Tuinstra; Jan-Willem Terpstra


Schizophrenia Research | 2003

SLV310, a molecule combining potent dopamine D2 receptor antagonism with serotonin reuptake inhibition

Cornelis G. Kruse; Tinka Tuinstra; A. Herremans; B.J. Van Vliet; S.K. Long; J.A.M. Van Der Heijden; Mayke B. Hesselink


Archive | 2003

2,3-Diaryl-pyrazolidine derivatives as neurotensin degrading enzyme inhibitors

Roelof W. Feenstra; Josephus H. M. Lange; Maria L. Pras-Raves; Cornelis G. Kruse; Herman H. van Stuivenberg; Tinka Tuinstra; Hiskias G. Keizer


Archive | 2003

Derivatives of 2,3-diaryl-pyrazolidine as inhibitors of neurotensin degrading enzyme.

Roelof W. Feenstra; Hiskias G. Keizer; Cornelis G. Kruse; Josephus H. M. Lange; Maria L. Pras-Raves; Tinka Tuinstra; Stuivenberg Herman H. Van

Researchain Logo
Decentralizing Knowledge